Vitamin D analogue therapy, cardiovascular risk and kidney function in people with Type 1 diabetes mellitus and diabetic nephropathy: a randomized trial

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Diabetic Medicine

• Publication date

  2015-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/dme.12606PMID 25307511
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diabetic nephropathy.

  2012cited by this paper
• Ambulatory Tonometric Blood Pressure Measurements in Patients with Diabetes

  2012cited by this paper
• Vitamin D Receptor Activation and Left Ventricular Hypertrophy in Advanced Kidney Disease

  2011cited by this paper
• Vitamin D Levels and Asymptomatic Coronary Artery Disease in Type 2 Diabetic Patients With Elevated Urinary Albumin Excretion Rate

  2011cited by this paper
• Vitamin D Deficiency and Coronary Artery Calcification in Subjects With Type 1 Diabetes

  2011cited by this paper
• Vitamin D Levels, Microvascular Complications, and Mortality in Type 1 Diabetes

  2011cited by this paper
• Short-term vitamin D receptor activation increases serum creatinine due to increased production with no effect on the glomerular filtration rate.

  2011cited by this paper
• Vitamin D Levels and Mortality in Type 2 Diabetes

  2010cited by this paper
• Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial.

  2010cited by this paper
• Oral paricalcitol in the treatment of patients with CKD and proteinuria: a randomized trial.

  2009cited by this paper
• Paricalcitol Reduces Albuminuria and Inflammation in Chronic Kidney Disease: A Randomized Double-Blind Pilot Trial

  2008cited by this paper
• Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality.

  2008cited by this paper
• The use of ambulatory tonometric radial arterial wave capture to measure ambulatory blood pressure: the validation of a novel wrist-bound device in adults

  2008cited by this paper
• Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: Blockade of compensatory renin increase

  2008cited by this paper
• Combination therapy with an angiotensin-converting enzyme inhibitor and a vitamin D analog suppresses the progression of renal insufficiency in uremic rats.

  2007cited by this paper
• 25-Hydroxyvitamin D levels and albuminuria in the Third National Health and Nutrition Examination Survey (NHANES III).

  2007cited by this paper
• Plasma N-terminal pro-B-type natriuretic peptide and mortality in type 2 diabetes

  2006cited by this paper
• Paricalcitol attenuates renal interstitial fibrosis in obstructive nephropathy.

  2006cited by this paper
• Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate

  2006cited by this paper
• Activated injectable vitamin D and hemodialysis survival: a historical cohort study.

  2005cited by this paper
• Antiproteinuric effect of oral paricalcitol in chronic kidney disease.

  2005cited by this paper
• Plasma N-terminal pro-brain natriuretic peptide as an independent predictor of mortality in diabetic nephropathy

  2004cited by this paper
• Plasma N-terminal pro-brain natriuretic peptide as a major risk marker for cardiovascular disease in patients with type 2 diabetes and microalbuminuria

  2004cited by this paper
• 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system.

  2002cited by this paper
• Cardiovascular calcification in end-stage renal disease.

  2002cited by this paper
• 1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system

  2002cited by this paper
• Effect of 1,25 (OH)2 vitamin D3 on glomerulosclerosis in subtotally nephrectomized rats.

  1998cited by this paper
• Assessment of arterial distensibility by automatic pulse wave velocity measurement. Validation and clinical application studies.

  1995cited by this paper
• Selection of routine method for determination of glomerular filtration rate in adult patients.

  1976cited by this paper

• Vitamin D, calcium, phosphates, and magnesium serum level and bone mineral density in patients with type 1 diabetes

  2026cites this paper
• Effects of Vitamin D Supplementation on Blood Pressure in Patients With Type 1 Diabetes Mellitus: A Systematic Review of Clinical Trials

  2025cites this paper
• Effects of Vitamin D Supplementation on Cardiovascular Outcomes in Chronic Kidney Disease Patients: A Systematic Review and Meta-Analysis

  2025cites this paper
• Association of Vitamin D Deficiency with Diabetic Nephropathy in Type 2 Diabetes: A Hospital-Based Cross-Sectional Study

  2025cites this paper
• Effectiveness of Vitamin D Supplementation on Biochemical, Clinical, and Inflammatory Parameters in Patients with Different Types of Diabetes: A Systematic Review and Meta-Analysis

  2025influential citation
• Effects of dietary supplementation in treatment and control of progression and complications of insulin-dependent diabetes mellitus: a systematic review with meta-analyses of randomized clinical trials

  2024cites this paper
• Vitamin B1 and calcitriol enhance glibenclamide suppression of diabetic nephropathy: Role of HMGB1/TLR4/NF-κB/TNF-α/Nrf2/α-SMA trajectories.

  2024cites this paper
• Vitamin D metabolism in diabetic nephropathy

  2024cites this paper
• NETosis: an emerging therapeutic target in renal diseases

  2023cites this paper
• Are There Any Pleiotropic Benefits of Vitamin D in Patients With Diabetic Kidney Disease? A Systematic Review of Randomized Controlled Trials

  2023cites this paper
• Vitamin D deficiency and development of complications in individuals with type 1 and type 2 diabetes: A cohort study.

  2023cites this paper
• EFFECTS OF VITAMIN D SUPPLEMENTATION IN DIABETIC KIDNEY DISEASE: A SYSTEMATIC REVIEW.

  2023cites this paper
• Vitamin D and Diabetic Kidney Disease

  2023cites this paper
• Novel biomarkers and therapeutic approaches for diabetic retinopathy and nephropathy: Recent progress and future perspectives

  2022cites this paper
• The Role of Vitamin D in Diabetic Nephropathy: A Translational Approach

  2022cites this paper
• Protective Role of Vitamin D Therapy in Diabetes Mellitus Type II

  2021cites this paper
• DMSO_A_303018 1681..1693

  2021cites this paper
• Vitamin D Analogs Can Retard the Onset or Progression of Diabetic Kidney Disease: A Systematic Review

  2021cites this paper
• Vitamin D/VDR Protects Against Diabetic Kidney Disease by Restoring Podocytes Autophagy

  2021cites this paper
• Paricalcitol in management of chronic kidney disease–mineral and bone disorder

  2021cites this paper
• Vitamin D ameliorates adipose browning in chronic kidney disease cachexia

  2020cites this paper
• Use of Paricalcitol as Adjunctive Therapy to Renin-angiotensin-aldosterone System Inhibition for Diabetic Nephropathy: A Systematic Review of the Literature.

  2019cites this paper
• The effects of vitamin D3 supplementation on some metabolic and inflammatory markers in diabetic nephropathy patients with marginal status of vitamin D: A randomized double blind placebo controlled clinical trial.

  2019cites this paper
• Role of Vitamin D and Its Analogues in Diabetic Nephropathy: A Meta‐analysis

  2019cites this paper
• Nephropathien bei Stoffwechselstörungen – Diabetische Nephropathie

  2019cites this paper
• Traitements complémentaires et parallèles du diabète Comité d’experts des Lignes directrices de pratique clinique de Diabète Canada

  2019cites this paper
• The role of vitamin D in the pathogenesis and treatment of diabetes mellitus: a narrative review

  2018cites this paper
• Moderate salt restriction with or without paricalcitol in type 2 diabetes and losartan-resistant macroalbuminuria (PROCEED): a randomised, double-blind, placebo-controlled, crossover trial.

  2018cites this paper
• Efficacy of Vitamin D 3 in Patients With Diabetic Nephropathy: An Updated Meta-Analysis

  2018cites this paper
• Effects of paricalcitol on cardiovascular outcomes and renal function in patients with chronic kidney disease

  2018cites this paper
• Vitamin D and Diabetes Mellitus.

  2018cites this paper
• Complementary and Alternative Medicine for Diabetes Diabetes Canada Clinical Practice Guidelines Expert Committee

  2018cites this paper
• Complementary and Alternative Medicine for Diabetes.

  2018cites this paper
• Vitamin D and diabetes mellitus: Causal or casual association?

  2017cites this paper
• Associação entre níveis reduzidos de 25-hidroxivitamina D e doença renal do diabetes

  2017cites this paper
• Efficacy of Vitamin D 3 in Patients With Diabetic Nephropathy: An Updated Meta-Analysis

  2017cites this paper
• Effects of 1, 25-dihydroxyvitamin D3 on expression of TGF-β1, CD68 and MCP-1 in type 2 diabetic nephropathy rat

  2017cites this paper
• VDR Activation Reduces Proteinuria and High-Glucose-Induced Injury of Kidneys and Podocytes by Regulating Wnt Signaling Pathway

  2017cites this paper
• Early introduction of oral paricalcitol in renal transplant recipients. An open‐label randomized study

  2017cites this paper
• Albuminuria Reduction after High Dose of Vitamin D in Patients with Type 1 Diabetes Mellitus: A Pilot Study

  2017cites this paper
• Vitamin D, Cardiovascular Disease and Risk Factors.

  2017cites this paper
• Effect of Vitamin D therapy on urinary albumin excretion, renal functions, and plasma renin among patients with diabetic nephropathy: A randomized, double-blind clinical trial

  2017cites this paper
• Vitamin D and Diabetic Complications: True or False Prophet?

  2016cites this paper
• Effect of paricalcitol on endothelial function and inflammation in type 2 diabetes and chronic kidney disease.

  2015cites this paper
• The renin–angiotensin–aldosterone system and calcium-regulatory hormones

  2015cites this paper
• The relationship between microvascular complications and vitamin D deficiency in type 2 diabetes mellitus

  2014cites this paper